Missing/wrong data?
Log in to edit
Safety, efficacy and immunogenicity of switching from innovator to biosimilar infliximab in patients with spondyloarthritis: a 6-month real-life observational study
scientific article published on 01 February 2017
Author/s
author: Simone Parisi, Piercarlo Sarzi-Puttini
Work details
Publication date
February 1, 2017
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.